子宫内膜增生性疾病长期管理专家建议

2022-07-29 妇产科相关专家组(统称) 中国计划生育和妇产科

近年来,越来越多的国内外学者意识到长期、综合、个体化的管理方案对于预防疾病复发、避免进展为恶行疾病、保护生育力、改善患者生活质量具有重要意义。随着宫腔镜手术的不断发展和普及,其已经成为子宫内膜增生性疾

中文标题:

子宫内膜增生性疾病长期管理专家建议

发布日期:

2022-07-29

简要介绍:

近年来,越来越多的国内外学者意识到长期、综合、个体化的管理方案对于预防疾病复发、避免进展为恶行疾病、保护生育力、改善患者生活质量具有重要意义。随着宫腔镜手术的不断发展和普及,其已经成为子宫内膜增生性疾病重要的治疗手段。而我国目前尚无子宫内膜增生性疾病长期管理相关共识及建议,缺乏规范性。为帮助我国广大临床工作者合理、规范操作,本“子宫内膜增生性疾病长期管理专家建议”将从子宫内膜增生和EP 两方面疾病分别阐述。

相关资料下载:
[AttachmentFileName(sort=1, fileName=子宫内膜增生性疾病长期管理专家建议.pdf)] GetToolGuiderByIdResponse(projectId=1, id=708981c002608338, title=子宫内膜增生性疾病长期管理专家建议, enTitle=, guiderFrom=中国计划生育和妇产科, authorId=0, author=, summary=近年来,越来越多的国内外学者意识到长期、综合、个体化的管理方案对于预防疾病复发、避免进展为恶行疾病、保护生育力、改善患者生活质量具有重要意义。随着宫腔镜手术的不断发展和普及,其已经成为子宫内膜增生性疾, cover=https://img.medsci.cn/20220817/1660705407523_5579292.png, journalId=0, articlesId=null, associationId=922, associationName=妇产科相关专家组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Fri Jul 29 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">近年来,越来越多的国内外学者意识到长期、</span><span style="color: #333333;">综合、个体化的管理方案对于预防疾病复发、避免进展</span><span style="color: #333333;">为恶行疾病、保护生育力、改善患者生活质量具有重要</span><span style="color: #333333;">意义。随着宫腔镜手术的不断发展和普及,其已经成为</span><span style="color: #333333;">子宫内膜增生性疾病重要的治疗手段。而我国目前尚</span><span style="color: #333333;">无子宫内膜增生性疾病长期管理相关共识及建议,缺乏</span><span style="color: #333333;">规范性。为帮助我国广大临床工作者合理、规范操作,</span><span style="color: #333333;">本&ldquo;子宫内膜增生性疾病长期管理专家建议&rdquo;将从子宫</span><span style="color: #333333;">内膜增生和EP 两方面疾病分别阐述。</span></p>, tagList=[TagDto(tagId=459515, tagName=子宫内膜增生性疾病)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2489, appHits=162, showAppHits=0, pcHits=447, showPcHits=2322, likes=2, shares=29, comments=6, approvalStatus=1, publishedTime=Sat Aug 20 10:00:00 CST 2022, publishedTimeString=2022-07-29, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=6, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Aug 17 11:02:22 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 20:40:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=子宫内膜增生性疾病长期管理专家建议.pdf)])
子宫内膜增生性疾病长期管理专家建议.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2117762, encodeId=230e211e76296, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210514/b62abbe5fa594953ac14bad5fb646e44/ea0b0ca034914c47a71f1b9209a1436f.jpg, createdBy=99b23067860, createdName=龙德来, createdTime=Sun Mar 05 19:06:50 CST 2023, time=2023-03-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2103652, encodeId=5c8a21036520e, content=不断的学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82978418232, createdName=ms8000001990171754, createdTime=Thu Dec 01 08:39:28 CST 2022, time=2022-12-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2094645, encodeId=bf912094645b3, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00038142021, createdName=ms3000000848423424, createdTime=Wed Oct 19 08:28:25 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242169, encodeId=3575124216969, content=学习,收益很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Tue Aug 30 22:32:21 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
    2023-03-05 龙德来 来自天津

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2117762, encodeId=230e211e76296, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210514/b62abbe5fa594953ac14bad5fb646e44/ea0b0ca034914c47a71f1b9209a1436f.jpg, createdBy=99b23067860, createdName=龙德来, createdTime=Sun Mar 05 19:06:50 CST 2023, time=2023-03-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2103652, encodeId=5c8a21036520e, content=不断的学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82978418232, createdName=ms8000001990171754, createdTime=Thu Dec 01 08:39:28 CST 2022, time=2022-12-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2094645, encodeId=bf912094645b3, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00038142021, createdName=ms3000000848423424, createdTime=Wed Oct 19 08:28:25 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242169, encodeId=3575124216969, content=学习,收益很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Tue Aug 30 22:32:21 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
    2022-12-01 ms8000001990171754 来自北京

    不断的学习中

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2117762, encodeId=230e211e76296, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210514/b62abbe5fa594953ac14bad5fb646e44/ea0b0ca034914c47a71f1b9209a1436f.jpg, createdBy=99b23067860, createdName=龙德来, createdTime=Sun Mar 05 19:06:50 CST 2023, time=2023-03-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2103652, encodeId=5c8a21036520e, content=不断的学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82978418232, createdName=ms8000001990171754, createdTime=Thu Dec 01 08:39:28 CST 2022, time=2022-12-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2094645, encodeId=bf912094645b3, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00038142021, createdName=ms3000000848423424, createdTime=Wed Oct 19 08:28:25 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242169, encodeId=3575124216969, content=学习,收益很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Tue Aug 30 22:32:21 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
    2022-10-19 ms3000000848423424

    学习一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2117762, encodeId=230e211e76296, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210514/b62abbe5fa594953ac14bad5fb646e44/ea0b0ca034914c47a71f1b9209a1436f.jpg, createdBy=99b23067860, createdName=龙德来, createdTime=Sun Mar 05 19:06:50 CST 2023, time=2023-03-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2103652, encodeId=5c8a21036520e, content=不断的学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82978418232, createdName=ms8000001990171754, createdTime=Thu Dec 01 08:39:28 CST 2022, time=2022-12-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2094645, encodeId=bf912094645b3, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00038142021, createdName=ms3000000848423424, createdTime=Wed Oct 19 08:28:25 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242169, encodeId=3575124216969, content=学习,收益很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Tue Aug 30 22:32:21 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
    2022-08-30 ms4000001291803254

    学习,收益很多

    0